Foot-and-Mouth Disease Virus Lacking the Leader Protein and Containing Two Negative DIVA Markers (FMDV LL3B3D A<sub>24</sub>) Is Highly Attenuated in Pigs
Inactivated whole-virus vaccines are widely used for the control of foot-and-mouth disease (FMD). Their production requires the growth of large quantities of virulent FMD virus in biocontainment facilities, which is expensive and carries the risk of an inadvertent release of virus. Attenuated recomb...
Asıl Yazarlar: | Michael Eschbaumer, Veronika Dill, Jolene C. Carlson, Jonathan Arzt, Carolina Stenfeldt, Peter W. Krug, John M. Hardham, Jacob E. Stegner, Luis L. Rodriguez, Elizabeth Rieder |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
MDPI AG
2020-02-01
|
Seri Bilgileri: | Pathogens |
Konular: | |
Online Erişim: | https://www.mdpi.com/2076-0817/9/2/129 |
Benzer Materyaller
-
Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency
Yazar:: John M. Hardham, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01) -
Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
Yazar:: Muneeswaran Selvaraj, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01) -
The Safety and Efficacy of New DIVA Inactivated Vaccines Against Lumpy Skin Disease in Calves
Yazar:: Gaetano Federico Ronchi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01) -
Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
Yazar:: Tinka Jelsma, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01) -
Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins
Yazar:: Anne Balkema-Buschmann, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)